ERBB2 and neoplasm: The antibody component of RC48 binds to HER2 on the tumor cell surface, triggering endocytosis and the release of monomethyl auristatin E (MMAE), which disrupts the intracellular microtubule network, leading to mitotic cell cycle arrest and apoptosis.